The Impact Of Cardiac Diseases During Pregnancy On Severe Maternal Morbidity And Mortality In Brazil by Campanharo et al.
RESEARCH ARTICLE
The Impact of Cardiac Diseases during
Pregnancy on Severe Maternal Morbidity and
Mortality in Brazil
Felipe F. Campanharo*1, Jose G. Cecatti2, Samira M. Haddad2, Mary A. Parpinelli2,
Daniel Born3, Maria L. Costa2, Rosiane Mattar1, Brazilian Network for Surveillance of
Severe Maternal Morbidity Study Group¶
1 Department of Obstetrics, Federal University of São Paulo (UNIFESP), São Paulo, Brazil, 2 Department of
Obstetrics and Gynecology, State University of Campinas (UNICAMP) School of Medicine, Campinas, Brazil,
3 Discipline of Cardiology, Federal University of São Paulo (UNIFESP), São Paulo, Brazil
¶ Membership of the Brazilian Network for Surveillance of Severe Maternal Morbidity Study Group is provided
in the Acknowledgments.
* favorette@hotmail.com
Abstract
Background
To evaluate maternal heart disease as a cause or complicating factor for severe morbidity
in the setting of the Brazilian Network for Surveillance of Severe Maternal Morbidity.
Methods and Findings
Secondary data analysis of this multicenter cross-sectional study was implemented in 27
referral obstetric units in Brazil. From July 2009 to June 2010, a prospective surveillance
was conducted among all delivery hospitalizations to identify cases of severe maternal mor-
bidity (SMM), including Potentially Life-Threatening Conditions (PLTC) and Maternal Near
Miss (MNM), using the new criteria established by the WHO. The variables studied
included: sociodemographic characteristics, clinical and obstetric history of the women;
perinatal outcome and the occurrence of maternal outcomes (PLTC, MNM, MD) between
groups of cardiac and non-cardiac patients. Only heart conditions with hemodynamic
impact characterizing severity of maternal morbidity were considered. 9555 women were
included in the Network with severe pregnancy-related complications: 770 maternal near
miss cases and 140 maternal death cases. A total of 293 (3.6%) cases were related to heart
disease and the condition was known before pregnancy in 82.6% of cases. Maternal near
miss occurred in 15% of cardiac disease patients (most due to clinical-surgical causes,
p<0.001) and 7.7% of non-cardiac patients (hemorrhagic and hypertensive causes,
p<0.001). Maternal death occurred in 4.8% of cardiac patients and in 1.2% of non-cardiac
patients, respectively.
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Conclusions
In this study, heart disease was significantly associated with a higher occurrence of severe
maternal outcomes, including maternal death and maternal near miss, among women pre-
senting with any severe maternal morbidity.
Introduction
About 287,000 maternal deaths occur each year worldwide, and considerable variation exists
between high and low/middle-income populations [1]. Maternal mortality (MM) is not only a
health indicator but also a social indicator, although there is a current trend to investigate the
impact of maternal morbidity on women’s health [2,3]. Maternal death has direct and indirect
causes. “Obstetric transition” occurs in regions of intermediate levels of income and develop-
ment that are beginning to show a trend towards decreasing maternal mortality and a propor-
tional increase in indirect causes. This has gained more relevance even in middle-income
countries [4].
Indirect maternal deaths result from conditions existing before pregnancy or recently devel-
oped disease unrelated to pregnancy, e.g. heart disease, HIV/AIDS, chronic hypertension, ane-
mia, cerebrovascular disease, infections. A recent data compilation demonstrated that indirect
causes accounted for at least one-fourth of all maternal deaths in Brazil [5]. A decrease in
maternal mortality constitutes the Millennium Development Goal 5. The target was to decrease
maternal mortality ratio (MMR) by 75% from 1990 to 2015. In Brazil, a 51% reduction in
MMR has occurred since 1990, however this decline is still insufficient considering that the
goal for Brazil is 35/100.000LB until 2015 [6].
Maternal morbidity, a more common condition, also affects women’s lives and is increas-
ingly valued. Then maternal near miss (MNM) has gained importance in the last 20 years [7]
and the World Health Organization (WHO) defined it as a condition in which “a woman
nearly died, but survived during pregnancy, childbirth or postpartum period, merely by chance
or good hospital care” [8].
Cardiac disease encompasses a broad and heterogeneous group of pathological conditions.
Heart conditions currently represent the main cause of indirect maternal obstetric deaths in
high-income countries [9,10]. Despite a low prevalence rate of heart disease in pregnancy
(around 1 to 4%), it significantly increases the risk of adverse perinatal events in both the
mother and fetus [11,12].
Pregnancy is associated with substantial and progressive hemodynamic changes starting
early in pregnancy, reaching their peak at the end of the second trimester and remaining rela-
tively constant until childbirth. Major alterations in pregnancy include a 30 to 50% increase in
both cardiac output and blood volume, in addition to decreased blood pressure. In cardiac
pregnant patients, these modifications may lead to clinical decompensation [12,13], exposing
these women to potentially life-threatening situations.
Heart disease may be either congenital or acquired. In the past, rheumatic heart disease was
the most common condition associated with pregnancy and it continues to predominate in low
and middle-income countries. In Brazil, the condition is still the most common cause of heart
disease in pregnancy with an estimated proportion of 50% [11,12]. In high-income countries,
congenital heart disease predominates, since advances in surgical/anesthetic techniques and
cardiac care have increased the survival of these females until fertile age [11,13].
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Many factors may delay pregnancy nowadays. Professional stability and desire to attain
financial security are some reasons for that. The prevalence of risk factors is increased in the
obstetric population, with hypertension, diabetes and dyslipidemia, justifying the increased
association between pregnancy and acquired heart disease [10,12]. Maternal-fetal risk is
directly related to maternal hemodynamic status [12] and the nature of the preexisting cardiac
lesion. Risk ranges from situations where pregnancy is well-tolerated with favorable outcomes
to situations of high maternal death risk (25 to 50%) [10]. The importance of heart disease as a
risk factor or determinant of maternal near miss events has not yet been fully evaluated. Heart
disease of any etiology theoretically increases the occurrence of maternal near miss episodes.
The main aim of the current study was to evaluate heart disease as a cause or complicating
factor for severe maternal morbidity and mortality in the setting of the Brazilian Network for
Surveillance of Severe Maternal Morbidity. Secondary aims were to compare sociodemo-
graphic, obstetric, perinatal characteristics and maternal morbidity features between women
with and without heart disease.
Method
The current study is a secondary data analysis of the Brazilian Network for Surveillance of
Severe Maternal Morbidity, focused on the impact of heart disease in the development of severe
maternal morbidity. The Network was a multicenter cross-sectional study, implemented in 27
referral obstetric units located in the entire Brazilian territory. During an one-year period, a
prospective surveillance of all obstetric hospitalizations was performed to identify cases of
PLTC, MNM and MD, using the WHO criteria [8]. Details of the current study methods have
already been published elsewhere [14,15].
Sample size calculation was based on 75 thousand deliveries. Surveillance of these deliveries
should be carried out to identify approximately 100 maternal deaths and 600 Maternal Near
Miss cases (based on a prevalence of 8 MNM cases per 1,000 deliveries [14], a ratio of maternal
deaths to live births of 140:100,000 and a 95% confidence interval). A wide geographical distri-
bution of participating centers was achieved, including all Brazilian regions.
The research team in each participating center carried out surveillance and data collection
of all hospitalized women meeting the inclusion criteria (presence of severe conditions). Data
was retrieved from patient medical charts and information was entered into previously
encoded forms, immediately after hospital discharge, transfer or death of the patient. Data was
transferred to a specific platform (OpenClinica1 version 2.5.5—Waltham, MA, EUA). There
was strict quality control of the data, with preparatory meetings for development and training
in the use of data collection forms, use of the standard operating procedures manual, technical
visits to each center (with random case selection for verification), in addition to systematic data
consistency verification by local investigators and study coordinators. Specific inconsistency
lists were available for each participating center. Some inconsistencies were logical and the
coordinating team only evaluated information on the respective database for correction. For
the remaining inconsistencies, a list was sent to each center where local researchers checked
medical charts and/or the health professional responsible for the patient to obtain necessary
information. Corrections were then entered into the database and new consistencies were run
until no more inconsistencies appeared [15].
Definition of variables
Study variables included sociodemographic characteristics; clinical and obstetric history;
details of personal history, occurrence of complications, maternal health care and existence of
delays; maternal outcomes recently defined by the WHO—Potentially Life-Threatening
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Conditions and criteria for Maternal Near Miss (clinical or laboratory evidence of organ dys-
function or failure, and management procedures for severity, including mechanical ventilation,
use of vasoactive drugs or hysterectomy due to infection or hemorrhage) [8]. Birth conditions
(number of live births, Apgar score at 5 minutes and weight) and neonatal outcome were also
used to compare groups.
Inclusion criteria for women with preexisting heart disorder or cardiac disease diagnosed
during pregnancy were identical to those of the original study, i.e., only cases presenting any
complication classified as a potentially life-threatening condition or maternal near miss event
were included. Women suffering from pre-existing heart disease or a cardiac condition identi-
fied during pregnancy had one of the conditions listed in Table 1. Conditions were specified
in the operating procedures manual of the study [15]. Women with cardiac arrhythmia in
normal hearts and normally functioning biologic valve prosthesis were excluded from the
study.
Data analysis
For the current analysis, women were divided into two groups: those with cardiac conditions
and women with the remaining complications. Women still pregnant at the end of study data
collection were excluded from analysis. Maternal characteristics were distributed and assessed
considering previous conditions: sociodemographic characteristics (age, ethnicity, years of
schooling, marital status, BMI), obstetric characteristics, pregnancy outcomes, delivery route
and neonatal outcome. Women with and without heart disease were compared and the differ-
ence between groups was evaluated by the chi-square test adjusted for clustering design effect.
The prevalence ratios (and their 95% confidence intervals) adjusted for cluster effect for
maternal death, maternal near miss, severe maternal outcomes, and potentially life-threatening
conditions were calculated and compared between both groups. The Maternal Near Miss
Ratio, Severe Maternal Outcomes Ratio (SMOR =MNM +MD), ratio of MNM to MD and
Maternal Mortality Ratio were estimated, according to WHO recommendations [8,16].
Major causes related to PLTC (first complication in the chain of events leading to these con-
ditions), the WHO criteria for MNM and perinatal outcomes were comparatively described
between both groups. The p-value obtained by the chi-square test, as well as 95% confidence
interval values of the prevalence ratio were adjusted for the clustering design effect. Each center
was assigned as a cluster and variability in response for each variable had low ICC values [17].
SPSS package (SPSS, Inc., 2009, Chicago, IL, www.spss.com) was the main statistical package
used in this analysis.
Table 1. Cardiac conditions included in the Brazilian Network for Surveillance of Severe Maternal
Morbidity
• Aortic aneurysm
• Non-operated cyanotic congenital heart diseases
• Previous acute myocardial infarction
• Mitral stenosis with atrial fibrillation
• Non-operated congenital heart disease with
hemodynamic repercussions (aortic coarctation)
• Need for anticoagulation therapy (mechanical
prosthesis)
• Atrial fibrillation with heart failure and ventricular
dysfunction
• Marfan syndrome with aortic involvement
• Pulmonary hypertension
• Eisenmenger syndrome
• Hypertrophic cardiomyopathy
• Dilated cardiomyopathy
• Congenital heart disease diagnosed as
complicated
• Severe valvular disease (aortic/mitral stenosis
—advanced functional class)
• Takayasu's disease
• Heart failure class II and III
• Peripartum cardiomyopathy
doi:10.1371/journal.pone.0144385.t001
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Ethical Statement
This study is a secondary analysis. All records were obtained from the database of the main
study, the Brazilian Network for Surveillance of Severe Maternal Morbidity. According to rules
of the sponsoring agency, the database is not of public domain. The main investigators are the
data owners responsible for data used for scientific purposes. We followed all the principles
regulating research in humans defined by the Brazilian National Health Council, as well as the
Declaration of Helsinki. There was no need for Informed Consent, since data collection was
obtained from postmortem medical records or after patients had been discharged from the
hospital. There was no contact with the subjects. Local IRBs (listed below) and the National
Research Ethics Committee (CONEP, Brazilian Ministry of Health) approved the study, under
letter of approval 097/2009.
The Review Boards of the following institutions reviewed and approved this study: Materni-
dade Cidade Nova Dona Nazarina Daou (Manaus, AM), Maternidade Climério de Oliveira
(Salvador, BA), Hospital Geral de Fortaleza (Fortaleza, CE), Hospital Geral Dr. César Cals
(Fortaleza, CE), Maternidade Escola Assis Chateaubriand (Fortaleza, CE), Hospital Materno
Infantil de Goiânia (Goiânia, GO), Hospital Universitário da Universidade Federal do Mara-
nhão (São Luis, MA), Maternidade Odete Valadares (Belo Horizonte, MG), Instituto de Saúde
Elıdio de Almeida (Campina Grande, PB), Hospital Universitário Lauro Wanderley da Univer-
sidade Federal da Paraíba (Joao Pessoa, PB), Centro Integrado de Saúde Amaury de Medeiros
(Recife, PE), Instituto de Medicina Integral Prof. Fernando Figueira (Recife, PE), Hospital das
Clınicas da Universidade Federal de Pernambuco (Recife, PE), Hospital das Clınicas da Univer-
sidade Federal do Paraná (Curitiba, PR), Hospital Maternidade Fernando Magalhaes (Rio de
Janeiro, RJ), Instituto Fernandes Figueira (Rio de Janeiro, RJ), Hospital das Clinicas da Univer-
sidade Federal do Rio Grande do Sul (Porto Alegre, RS), Faculdade de Medicina de Botucatu
da Universidade Estadual Paulista (Botucatu, SP), Hospital da Mulher da Universidade Esta-
dual de Campinas (Campinas, SP), Hospital e Maternidade Celso Pierro da Pontifícia Universi-
dade Católica (Campinas, SP), Hospital Israelita Albert Einstein (São Paulo, SP), Faculdade de
Medicina de Jundiaí (Jundiaí, SP), Hospital das Clınicas da Faculdade de Medicina de Ribeirão
Preto da Universidade de São Paulo (Ribeirão Preto, SP), Santa Casa de Limeira (Limeira, SP),
Santa Casa de São Carlos (São Carlos, SP), Casa Maternal Leonor Mendes de Barros (São
Paulo, SP), Hospital São Paulo da Universidade Federal de São Paulo (São Paulo, SP).
Results
During the one-year study period, 82,388 women were admitted in 27 participating centers,
with 82,144 livebirths. Among these women, 9555 had severe pregnancy-related complications
and were included in the study. Data on cardiac conditions were available for 8243 of these
women. A total of 293 cases (3.1%) involved the presence of heart disease (Fig 1). Of these, 242
(82.6%) had a known heart disorder prior to pregnancy, and 51 (17.4%) had been initially diag-
nosed during pregnancy. Among the 14 maternal obstetric deaths in cardiac patients, 42.8%
(6/14) were diagnosed during pregnancy.
Sociodemographic features differed in groups. A higher frequency of advanced maternal
age, a partner and a Body Mass Index indicative of underweight occurred among cardiac
patients (Table 2). These women tended to seek prenatal care at the same referral center, had a
higher number of previous pregnancies/deliveries and earlier delivery hospitalizations, particu-
larly between 22–33 weeks of gestation. However, gestational age at delivery did not show any
statistically significant differences between groups, as was the case also for prenatal care fund-
ing, number of previous C-sections/abortion, time since last delivery and route of delivery
(Table 3).
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The risk of occurring MD, MNM, or Severe Maternal Outcome (SMO =MNM+MD) was
estimated to be twofold to almost fourfold higher in cardiac disease patients than in non-car-
diac patients. Consequently, the MNM:MD ratio was lower in cardiac patients, meaning that
the mortality index increased twofold among these women (Table 4).
Major causes of PLTC differed significantly between groups. While hypertension and hem-
orrhage were the most common causes associated with non- cardiac patients, clinical-surgical
conditions, e.g. shock, respiratory failure and thromboembolism were significantly more com-
mon among cardiac disease patients. The WHOmanagement and laboratory criteria for MNM
were similar in both groups. However, clinical criteria were more common in the cardiac
group (Table 5).
The level of treatment complexity required for both groups was also different. ICU admis-
sion was much more common in cardiac patients (52.6%) than in non-cardiac patients
(22.6%). Although neonatal death rate almost doubled and the rate of low birthweight was
slightely higher among cardiac patients, perinatal outcomes were quite similar between both
groups (Table 6).
Discussion
We performed an analysis of the role of heart disease and its impact on women with severe
maternal morbidity evaluated by the Brazilian Network for Surveillance of Severe Maternal
Morbidity. Among women with cardiac disease the estimated risk of MNM doubled and that
of MD increased almost fourfold, compared with non-cardiac patients. These rates corre-
sponded to the most frequent clinical-surgical causes of MNM and MD. The prevalence rate of
pregnancy-related heart disease was 3.1% in severe maternal morbidity cases in this Brazilian
Fig 1. Flow chart of women in the study.
doi:10.1371/journal.pone.0144385.g001
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study. Heart disease prior to pregnancy was responsible for 82.6% of cases, in disagreement
with data in the literature, where most conditions were first diagnosed during pregnancy. This
number corresponds to a prevalence rate of 35.6 cases per 10,000 births, which is much higher
than data reported for a recent population-based cohort study carried out in the Netherlands
[18].
To the best of our knowledge, despite the existence of other prospective studies of heart dis-
orders with corresponding maternal morbidity and mortality [18], this is the first study to use
the recent WHO standardized definitions and criteria for different levels of morbidity [8,16].
This is a positive aspect of the current study, which provides standardized results to compare
with other findings similarly obtained in the future from other populations.
Pregnancy poses significant challenge to cardiovascular physiology. Previously unknown
heart disorders may first become evident during pregnancy, when diagnosis was made in
17.4% of cases in this network. The most common symptoms resembling heart failure (exer-
tional dyspnea, palpitations and edema) are often underestimated or confused with findings
that typically occur during normal pregnancy. There may then be a delay and difficulty in mak-
ing the correct diagnosis [12,19]. In Brazil, as in other parts of the world, maternal mortality
due to direct causes has declined in the last decades. In contrast, those due to indirect causes
Table 2. Distribution of womenwith severe maternal morbidity by sociodemographic characteristics according to the presence of any cardiac
disease.
Sociodemographic characteristics Cardiac Disease p*
Yes No
Age (Years)
10–19 14.0 17.7 <0.001
20–34 58.4 65.3
35–49 27.6 17.0
(n) (293) (7950)
Skin Color
White 46.0 43.2 0.592
Others 54.0 56.8
(n) (235) (6419)
Schooling (Years)
Primary 50.2 46.4 0.531
High School 44.6 47.7
University 5.2 5.9
(n) (211) (6233)
Marital status
Partner 65.1 53.6 0.014
No Partner 34.9 46.4
(n) (249) (7011)
Body Mass Index
Underweight 26.4 14.6 <0.002
Adequate 35.1 26.9
Overweight / Obesity 38.5 58.5
(n) (148) (3692)
* χ2 test adjusted for cluster effect
Values in bold mean they are statistically significant.
doi:10.1371/journal.pone.0144385.t002
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Table 3. Distribution of womenwith severe maternal morbidity by some obstetric characteristics
according to the presence of any cardiac disease.
Obstetric characteristics Cardiac Disease p*
Yes No
Prenatal care
Same unit 47.3 23.6 < 0.001
Other 49.8 71.4
No prenatal care 2.8 5.0
(n) (283) (7292)
Funding prenatal care
Public 93.5 89.0 0.06
Private 3.0 5.0
No prenatal care 3.4 6.0
(n) (263) (6667)
No. of pregnancies
1 33.9 41.4 0.003
2–3 38.7 38.8
4 27.4 19.8
(n) (292) (7927)
No. previous deliveries
0 39.7 47.9 0.002
1–2 41.1 38.8
3 19.2 13.3
(n) (292) (7927)
No. previous abortions
0 75.3 77.3 0.311
1 24.7 22.7
(n) (292) (7926)
No. previous C-sections
0 73.1 75.4 0.078
1 21.4 17.1
2 5.5 7.5
(n) (290) (7858)
Years since last delivery
<2 12.2 10.6 0.73
2–9 68.3 71.1
10 19.5 18.3
(n) (123) (2375)
Adequacy of prenatal care
Adequate 76.7 75.0 0.602
Inadequate 23.3 25.0
(n) (275) (7629)
Gestational age at admission
< 22 weeks 8.9 5.4 0.002
22–33 weeks 32.6 24.0
34–36 weeks 19.2 19.6
37 weeks 31.3 46.5
Postpartum 7.9 4.5
(n) (291) (7761)
(Continued)
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Table 3. (Continued)
Obstetric characteristics Cardiac Disease p*
Yes No
Onset of labor #a
Spontaneous 24.9 32.7 0.102
Induced 9.1 10.2
No labor 61.8 51.6
Abortion 4.1 5.5
(n) (241) (7311)
Gestational age at delivery #b
< 22 Weeks 3.8 3.6 0.444
22–33 Weeks 23.9 19.0
34–36 Weeks 20.1 20.9
37 Weeks 52.1 56.5
(n) (234) (7006)
Pregnancy outcome/Route of delivery #c
Vaginal birth 19.3 25.4 0.073
C-Section 76.7 69.2
Abortion / Ectopic 4.0 5.4
(n) (249) (7369)
* χ2 test adjusted for cluster effect
Values in bold mean they are statistically significant.
doi:10.1371/journal.pone.0144385.t003
Table 4. Cardiac disease as the main cause of severematernal morbidity andmortality and corre-
sponding indicators.
Morbidity/Mortality Cardiac Disease PRadj [95% CI]*
Yes No
n (%) n (%)
Maternal outcome
MD 14 (4.8) 96 (1.2) 3.7 [2.0–6.9]
MNM 44 (15.0) 612 (7.7) 2.0 [1.3–3.2]
SMO 58 (19.8) 708 (8.9) 2.2 [1.7–2.8]
PLTC 235 (80.2) 7242 (91.1) 0.4 [0.3–0.6]
Total (293) (7950) --
Health Indicators
MNM ratio 0.5/1000 LB 7.5/1000 LB
SMOR 0.7/1000 LB 8.6/1000 LB LB 82,144
MNM:MD ratio 3.1: 1 6.4: 1
MMR 17.0/100,000 LB 115.7/100,000 LB
* For each group the prevalence ratio, adjusted for cluster effect, was determined for “cardiac disease”
versus “non-cardiac disease”.
PR: Prevalence Ratio; CI: Confidence Interval; MD: Maternal Death; MNM: Maternal Near Miss; PLTC:
Potentially Life-Threatening Condition; SMOR: Severe Maternal Outcome Ratio; MMR: Maternal Mortality
Ratio; LB: Live Birth. Values in bold mean they are statistically significant.
doi:10.1371/journal.pone.0144385.t004
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increased. Heart disease is one of the main causes of MM in high-income countries [11].
Emphasis should therefore be placed on heart disease for the development of interventions to
reduce maternal morbidity and mortality.
Pregnancy in women over 35 years of age was significantly more common in cardiac
patients. The delay in childbirth until later in life and the increased prevalence of risk factors in
this population (hypertension, diabetes and dyslipidemia), may explain the association
Table 5. Main causes of PLTC and proportion of WHO´s Maternal Near Miss criteria identified among
womenwith severe maternal morbidity according to the presence of any cardiac disease.
Variable Cardiac Disease
Yes No p*
Main causes of PLTC
Hypertensive 38.6 71.8 <0.001
Hemorrhagic 10.6 23.2 <0.001
Infectious 0.7 1.1 0.341
Clinical-Surgical 53.9 9.6 <0.001
(n) (293) (7950)
WHO MNM Criteria
Clinical criteria 75.9 54.3 <0.002
Laboratorial criteria 55.2 57.3 0.754
Management criteria 63.8 64.9 0.885
(n) (58) (707) --
*χ2 test adjusted for cluster effect
Values in bold mean they are statistically significant.
doi:10.1371/journal.pone.0144385.t005
Table 6. Distribution of womenwith severe maternal morbidity by neonatal outcomes according to the
presence of any cardiac disease.
Variable Cardiac Disease
Yes No p*
Neonatal outcome
Hospital Discharge 71.1 76.2 0.282
Hospital Admission 23.9 20.6
Neonatal Death 4.1 2.4
Transferred 0.9 0.9
(n) (218) (6.382)
Condition at birth
Live Birth 96.1 95.9 0.887
(n) (230) (6.851)
Apgar 5 Min < 7 8.7 6.2 0.154
(n) (219) (6.676)
Low birth weight <2500g 44.5 37.7 0.225
(n) (220) (6.730)
Weight (g) 2510.9 2667.1
(IC 95%) [2.351–2670] [2527–2807]
*χ2 test adjusted for cluster effect
doi:10.1371/journal.pone.0144385.t006
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between pregnancy and acquired heart disease among older women, in agreement with other
studies [12,18]. There was a significantly higher rate of partners among women with severe
complications and heart disease. A partner or other family members can significantly influence
a woman’s decison to seek medical care. Nevertheless, there is no clear correlation between
these factors, apart from a higher association between older age and higher parity. A clear asso-
ciation between delays and outcome severity has already been reported in the literature, as well
as in our original study [20].
Obesity is an aggravating factor for several morbid conditons that occur during pregnancy.
However, in the present study this condition was significantly more common among women
with complications other than heart disease. Since this variable had a higher proportion of
missing data, this represents a limitation of the current study. The cardiac group had higher
parity, probably due to increased maternal age. As heart disorder was previously known in the
majority of cases, it can thus be assumed that family planning counseling had failed for them
[21,22].
Women with heart disorders, especially those with congenital heart disease, tend to become
pregnant earlier [23], underestimating the risk for their health condition [24]. Adolescence is a
common situation found in 14% of cardiac patients in the study, when ambivalent feelings and
equivocal perceptions are much more frequent [25]. Family planning advice is required in
these young patients, if strategies are to include a reduction in maternal risk conditions.
Although gestational age at birth did not differ between both groups, at the time of hospital-
ization it did. Admission was significantly earlier and had a longer duration in cardiac patients.
Postpartum hospitalization rates almost doubled in these women, compared to those without
heart disease (7.9 X 4.5%, data not shown). The postpartum period is critical, since pregnancy
cardiovascular functions change abruptly after birth. Vena cava decompression causes an
immediate increase in preload. Autotransfusion by uterine blood volume and redistribution of
edema/interstitial fluid with resultant volume overload may lead to pulmonary congestion and
heart failure. Some changes, however, may last up to six months [26]. This represents a special
group of women at higher risk of complications, even when childbirth occurred without any
additional damage to the pre-existing condition. These women deserve postpartum intensive
care for early detection and adequate management of potential clinical decompensation.
Despite the already known high rates of Cesarean section among Brazilian women overall
population, they are even higher among those with severe maternal morbidity. Vaginal birth is
associated with lower blood loss, faster pospartum recovery and lower risk of thromboembo-
lism, while Cesarean section produces more abrupt hemodynamic changes, increasing the risk
of postpartum hemorrhage [27]. Although there is insufficient evidence to fully support that
Cesarean section best resolves pregnancies with severe maternal complications, it is increas-
ingly common when this condition is present. In the current study, Cesarean section rates were
elevated, but still higher among cardiac patients, reaching 77%. In a recent Dutch study, the
rate of Cesarean section in the general population was 13%, while in the cardiac disease popula-
tion it achieved 54.8% [18].
The prevalence ratio of maternal death in the current study was 3.7 times higher in the car-
diac group. This was no surprise, since heart disease is the main cause of indirect maternal
mortality worldwide. Data reinforce the impact of heart conditions on maternal health. In con-
trast, the estimated risk of developing Maternal Near Miss in this group doubled, supporting
the need for deeper analysis of these survivors to understand health care problems and health-
disease processes in this specific population. Although both in Brazil and other emerging coun-
tries, heart disease still represents a smaller portion of maternal morbidity and mortality in
absolute numbers, its impact becomes clear when the reduced MNM:MD ratio and elevated
mortality index are confirmed.
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Cardiac decompensation may also worsen perinatal outcomes. Among the conditions
potentially determinant of this result are a higher incidence of preterm, low birthweight, fetal
growth restriction and low Apgar score. Our study showed that perinatal mortality rates almost
doubled among women with cardiac diseases, however this difference was not statistically sig-
nificant. Preterm birth among cardiac patients, whose previously described rates were around
38% 18, affected more than 45% of newborn infants equally in both groups. Similar neonatal
outcomes regarding birthweight and Apgar scores were found for both groups, reinforcing
what has already been described 27. A Swedish population-based study identified among
women with cardiac diseases a significantly higher occurrence of lower birthweight, lower ges-
tational length, preterm and small for gestational age for the neonates, however the cardiac
condition was due only to congenital heart diseases [28].
Some positive points in this study were a large sample size, rigorous quality control data sys-
tem and the inclusion of all Brazilian geographical regions. A possible limitation of the study
was the lack of heart disease categorization (acquired or congenital, valvular, arrhythmic, ische-
mic or myocardial injury). Details on the use of specific medications and gestational age at the
time of cardiac decompensation were lacking, since this assessment was not part of the aims of
the initial Network study. Information was missing in a high proportion of cases for some vari-
ables due to retrospective data collection after patient discharge from the hospital. Medical
charts had no enough detailed data available in the majority of participating centers.
Conclusion
In the Brazilian Network for Surveillance of Severe Maternal Morbidity, heart disease was sig-
nificantly associated with a higher occurrence of maternal near miss events and maternal
deaths. Potentially life-threatening conditions differed among groups. Clinical-surgical causes
and clinical criteria for maternal near miss events were more common in the cardiac group. In
the current study, the majority of complications occurred in cardiac patients with known heart
disorders before pregnancy, reinforcing the importance of family planning counseling and spe-
cialized prenatal follow-up care in this group.
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